Results 21 to 30 of about 850,844 (261)

Prognosis of patients with coronary vasospasm after successful resuscitation from ventricular fibrillation

Journal of Arrhythmia, 2012
Ventricular fibrillation (VF) is an important cause of sudden cardiac death in patients with coronary vasospasm. Intensive medical treatment against coronary vasospasm is most important for prevention of VF recurrence, and the efficacy of implantable ...
Akiko Ishihara, MD, Takahiro Tanaka, MD, Yu Otsu, MD, Tomoyuki Yamada, MD, Toru Tamaki, MD, Akihito Kosaka, MD, Yoshiro Kamoi, MD, Yuji Kira, MD, Ph.D.   +7 more
doaj   +2 more sources

Relation of Perivascular Adipose Tissues on Computed Tomography to Coronary Vasospasm [PDF]

Reviews in Cardiovascular Medicine
Background: Coronary computed tomography angiography (CTA) can be used to quantitatively and qualitatively evaluate the characteristics of perivascular adipose tissue (PVAT), including PVAT volume and perivascular fat attenuation index
Kazunari Asada, Yuichi Saito, Hiroyuki Takaoka, Hideki Kitahara, Yoshio Kobayashi   +4 more
doaj   +2 more sources

A Case of Coronary Vasospasm after Repeat Rituximab Infusion

Case Reports in Cardiology, 2015
Coronary artery vasospasm (CAV) can be triggered by medication reactions. CAV occurring after multiple exposures to rituximab has not been previously described.
Calvin Ke, Amit Khosla, Margot K. Davis, Cameron Hague, Mustafa Toma   +4 more
doaj   +2 more sources

On the Precipice of Disaster – Fulminant Acute Myocarditis Mimicking ST-Elevation Myocardial Infarction in a Young Patient [PDF]

Romanian Journal of Cardiology, 2021
Although acute myocarditis and coronary vasospasm are common differential diagnoses in the case of young patients with persistent ST elevation, the association of coronary vasospasm and acute fulminant myocarditis is a rare situation. We present the case
Ruxandra DRAGOI GALRIHNO, Anca BALINISTEANU, Vladimir BRATU, Andrea CIOBANU, Laura MITREA, Alina NICULA, Dragos VINEREANU   +6 more
doaj   +1 more source

Recurrent Ventricular Fibrillation Due to Coronary Vasospasm Without Preceding ST-Segment Elevation or Chest Pain. [PDF]

JACC Case Rep
William J, Ferreira LZ, Voskoboinik A, Chieng D, Mariani JA, Patel H.   +5 more
europepmc   +2 more sources

Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis

Frontiers in Cardiovascular Medicine, 2023
Background Coronary artery spasm (CAS), encompassing epicardial and microvascular spasm, is increasingly recognized as cause of angina in patients with non-obstructive coronary artery disease (ANOCA).
J. Woudstra, C. Vink, Diantha J. M. Schipaanboord, E. Eringa, H. D. den Ruijter, R. Feenstra, C. Boerhout, M. Beijk, Guus A. de Waard, P. Ong, A. Seitz, U. Sechtem, J. Piek, T. P. van de Hoef, Y. Appelman   +14 more
semanticscholar   +1 more source

Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
Background A relevant proportion of patients with suspected coronary artery disease undergo invasive coronary angiography showing normal or nonobstructive coronary arteries.
N. Mileva, S. Nagumo, T. Mizukami, J. Sonck, C. Berry, E. Gallinoro, G. Monizzi, A. Candreva, D. Munhoz, D. Vassilev, M. Penicka, E. Barbato, B. de Bruyne, C. Collet   +13 more
semanticscholar   +1 more source

Recurrent Coronary Vasospasm: A Case of Kounis Syndrome from Anaphylaxis to Contrast Dye

Methodist DeBakey Cardiovascular Journal, 2022
Kounis syndrome is characterized by acute coronary syndrome due to coronary vasospasm or thrombosis following exposure to an allergic stimulus. The presentation can be compounded by cardiovascular collapse due to cardiogenic shock from coronary vasospasm
Katherine Lee Chuy, Proddutur R. Reddy, Aviral Vij   +2 more
doaj   +1 more source

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm

PLoS ONE, 2022
Background Coronary vasospasm is a known side effect of 5-FU (fluorouracil) therapy. Beyond switching to non-5FU-based chemotherapy, there are no established treatments for 5-FU associated coronary vasospam.
A. Zafar, Z. Drobni, M. Lei, Carlos A Gongora, Thiago Quinaglia, Uvette Lou, Ramya C. Mosarla, Sean P. Murphy, Maeve Jones-O’Connor, Ali Mahmood, Sarah B Hartmann, H. Gilman, C. Weekes, Ryan D. Nipp, J. Clark, Jeffrey W. Clark, L. Blaszkowsky, E. Tavares, T. Neilan   +18 more
semanticscholar   +1 more source

Successful recognition and management of life-threatening multivessel coronary artery vasospasm after conventional coronary artery bypass grafting.

International Journal of Endorsing Health Science Research, 2023
Background: The occurrence of native coronary artery vasospasm after coronary artery bypass grafting (CABG) is a rare phenomenon with potentially catastrophic outcomes.
Abdul Azeem Khan, Ahson Memon, Ghufranullah Khan, Shakir Lakhani, Vinod Kumar   +4 more
doaj   +1 more source